These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 21354674)

  • 1. The many faces of the adamantyl group in drug design.
    Liu J; Obando D; Liao V; Lifa T; Codd R
    Eur J Med Chem; 2011 Jun; 46(6):1949-63. PubMed ID: 21354674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugates of desferrioxamine B (DFOB) with derivatives of adamantane or with orally available chelators as potential agents for treating iron overload.
    Liu J; Obando D; Schipanski LG; Groebler LK; Witting PK; Kalinowski DS; Richardson DR; Codd R
    J Med Chem; 2010 Feb; 53(3):1370-82. PubMed ID: 20041672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and water solubility of adamantyl-OEG-fullerene hybrids.
    Bar-Shir A; Engel Y; Gozin M
    J Org Chem; 2005 Apr; 70(7):2660-6. PubMed ID: 15787557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic 3-hydroxypyridin-4-ones: potential antimalarial agents.
    Dehkordi LS; Liu ZD; Hider RC
    Eur J Med Chem; 2008 May; 43(5):1035-47. PubMed ID: 17869385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties.
    Villhauer EB; Brinkman JA; Naderi GB; Burkey BF; Dunning BE; Prasad K; Mangold BL; Russell ME; Hughes TE
    J Med Chem; 2003 Jun; 46(13):2774-89. PubMed ID: 12801240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of malaria by drug-mediated iron deprivation.
    Hershko C; Cabantchik ZI
    Isr J Med Sci; 1994 Nov; 30(11):840-5. PubMed ID: 7982777
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug evaluation: deferitrin (GT-56-252; NaHBED) for iron overload disorders.
    Barton JC
    IDrugs; 2007 Apr; 10(4):270-81. PubMed ID: 17390251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug evaluation: Deferitrin for iron overload disorders.
    Barton JC
    IDrugs; 2007 Jul; 10(7):480-90. PubMed ID: 17642018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of iron chelators: syntheses and iron (III) complexing abilities of tripodal tris-bidentate ligands.
    d'Hardemare Adu M; Torelli S; Serratrice G; Pierre JL
    Biometals; 2006 Aug; 19(4):349-66. PubMed ID: 16841245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A facile method for the synthesis of 2-(3-hydroxy-1-adamantyl)-2-oxoacetic acid and it's optimization.
    Wang HF; Gan R; Zhou J; Liao Q; Wang TB; Zhong CL; Xiang YY; Lin HB; Hu XN
    Pak J Pharm Sci; 2018 Jul; 31(4):1393-1397. PubMed ID: 30033425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of dipeptidylpeptidase-4 inhibitors.
    Scheen AJ
    Diabetes Obes Metab; 2010 Aug; 12(8):648-58. PubMed ID: 20590741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of iron chelators for the treatment of iron overload disease and cancer.
    Kalinowski DS; Richardson DR
    Pharmacol Rev; 2005 Dec; 57(4):547-83. PubMed ID: 16382108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research progress on iron chelator for malaria therapy].
    Huang F; Tang LH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Aug; 23(4):250-3. PubMed ID: 16296623
    [No Abstract]   [Full Text] [Related]  

  • 14. Malaria and iron: history and review.
    Weinberg ED; Moon J
    Drug Metab Rev; 2009; 41(4):644-62. PubMed ID: 19764831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron chelators for clinical use.
    Tilbrook GS; Hider RC
    Met Ions Biol Syst; 1998; 35():691-730. PubMed ID: 9444773
    [No Abstract]   [Full Text] [Related]  

  • 17. Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes.
    Scherbaum WA
    Diabetes Obes Metab; 2009 May; 11 Suppl 2():1-2. PubMed ID: 19385977
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent advances in antimalarial drug development.
    Vangapandu S; Jain M; Kaur K; Patil P; Patel SR; Jain R
    Med Res Rev; 2007 Jan; 27(1):65-107. PubMed ID: 16700012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and 11β hydroxysteroid dehydrogenase 1 inhibition of thiazolidine derivatives with an adamantyl group.
    Kwon SW; Kang SK; Lee JH; Bok JH; Kim CH; Dal Rhee S; Jung WH; Kim HY; Bae MA; Song JS; Ha DC; Cheon HG; Kim KY; Ahn JH
    Bioorg Med Chem Lett; 2011 Jan; 21(1):435-9. PubMed ID: 21093259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New adamantane derivatives with sigma affinity and antiproliferative activity.
    Riganas S; Papanastasiou I; Foscolos GB; Tsotinis A; Dimas K; Kourafalos VN; Eleutheriades A; Moutsos VI; Khan H; Margarita P; Georgakopoulou S; Zaniou A; Theodoropoulou M; Mantelas A; Pondiki S; Vamvakides A
    Med Chem; 2012 Jul; 8(4):569-86. PubMed ID: 22530894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.